IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope. by Xuchu Que, George F Widhopf, Shahzada Amir, Karsten Hartvigsen, Lotte F Hansen, Douglas Woelkers, Sotirios Tsimikas, Christoph J Binder, Thomas J Kipps, Joseph L Witztum

Get full text

Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after... by Januario E. Castro, Paula A. Lengerke-Diaz, Juliana Velez Lujan, Michael Y. Choi, Eider F. Moreno-Cortes, Jose V. Forero, Juan Esteban Garcia-Robledo, Chaja Jacobs, Colin McCarthy, Alaina Heinen, Carlos I. Amaya-Chanaga, Thomas J. Kipps

Get full text

Targeting PRDX1 impairs acute myeloid leukemic blasts and stem cells by disrupting redox homeostasis by Zhenghao Li, Guangci Liu, Ziren Chen, Keming Li, Zhe Yu, Chao He, Xinyu Ying, Danling Huang, Chengtian Tao, Sajid Khan, Yimeng Wang, Fang-Lin Zhang, Huan Li, Yun Chen, Jingfeng Zhou, Li Yu, Thomas J. Kipps, Yongxian Cheng, Suping Zhang

Get full text